Research Articles | Page 34 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria Mar 2024 Haematologica Paroxysmal Nocturnal Hemoglobinuria (PNH)
Use of Immunosuppressive therapy for management of myelodysplastic syndromes: a systematic review and meta-analysis Apr 2019 Haemotologica Myelodysplastic Syndromes (MDS)
Validation of International Working Group response criteria in higher-risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium Dec 2020 Cancer Medicine Myelodysplastic Syndromes (MDS)
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience Nov 2020 Leukemia & Lymphoma Myelodysplastic Syndromes (MDS)
Venetoclax and Hypomethylating Agents (HMAs) Induce High Response Rates in MDS, Including Patients After HMA Therapy Failure Jul 2020 Blood Advances Myelodysplastic Syndromes (MDS)
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases Apr 2023 Internal and Emergency Medicine Myelodysplastic Syndromes (MDS)
What causes aplastic anaemia? Apr 2023 Leukemia Aplastic Anemia
Where There's Smoke, There's Fire: Inflammation Drives MDS Jul 2020 Trends in immunology Myelodysplastic Syndromes (MDS)
Whole-genome sequencing identifies novel predictors for hematopoietic cell transplant outcomes for patients with myelodysplastic syndrome: a CIBMTR study Apr 2023 Journal of Hematology & Oncology Myelodysplastic Syndromes (MDS)
Why do we not have more drugs approved for MDS? A critical viewpoint on novel drug development in MDS Jul 2023 Blood Advances Myelodysplastic Syndromes (MDS)